个人中心 - 老虎社区

zetheraine

IP属地：未知

帖子 · 17帖子 · 17
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- zetherainezetheraine
  ·2021-12-23
  Buy or not?
  Biogen shares fell 1.2% in early trading<blockquote>百健(Biogen)股价早盘下跌1.2%</blockquote>
  Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc
  Biogen shares fell 1.2% in early trading<blockquote>百健(Biogen)股价早盘下跌1.2%</blockquote>
  2,115 评论
  1
  分享
  举报
- zetherainezetheraine
  ·2021-12-23
  Is this the chance for 1.5k price target?
  非常抱歉，此主贴已删除
  1,846 1
  2
  分享
  举报
- zetherainezetheraine
  ·2021-12-23
  $Microsoft(MSFT)$should I sell it now?
  2,698 4
  4
  分享
  举报
- zetherainezetheraine
  ·2021-12-22
  $Tesla Motors(TSLA)$$1500 in 2022?
  2,320 1
  3
  分享
  举报
- zetherainezetheraine
  ·2021-12-22
  $American Virtual Cloud Technologies, Inc.(AVCT)$Fell again? :(
  2,191 评论
  2
  分享
  举报
- zetherainezetheraine
  ·2021-12-18
  Ok
  非常抱歉，此主贴已删除
  3,411 1
  2
  分享
  举报
- zetherainezetheraine
  ·2021-12-17
  $American Virtual Cloud Technologies, Inc.(AVCT)$up to 1.80?
  2,603 评论
  1
  分享
  举报
- zetherainezetheraine
  ·2021-12-15
  $Galera Therapeutics, Inc.(GRTX)$Close at 3.30 tonight? Possible?
  2,083 评论
  2
  分享
  举报
- zetherainezetheraine
  ·2021-12-15
  $Galera Therapeutics, Inc.(GRTX)$up to 3.05?
  2,740 评论
  1
  分享
  举报
- zetherainezetheraine
  ·2021-12-14
  $Nuverra Environmental Solutions, Inc.(NES)$omgness it dropped after I buy 😔
  2,045 评论
  点赞
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4098271159372920","uuid":"4098271159372920","gmtCreate":1635169102872,"gmtModify":1635755740902,"name":"zetheraine","pinyin":"zetheraine","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":6,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.19%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.92%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691207186,"gmtCreate":1640190155529,"gmtModify":1640190155636,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"Buy or not?","listText":"Buy or not?","text":"Buy or not?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691207186","repostId":"1104039472","repostType":4,"repost":{"id":"1104039472","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640184691,"share":"https://www.laohu8.com/m/news/1104039472?lang=zh_CN&edition=full","pubTime":"2021-12-22 22:51","market":"us","language":"en","title":"Biogen shares fell 1.2% in early trading<blockquote>百健(Biogen)股价早盘下跌1.2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1104039472","media":"Tiger Newspress","summary":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc","content":"<p>Biogen&nbsp;shares&nbsp;fell&nbsp;1.2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p><p><blockquote>百健(Biogen)股价早盘下跌1.日本厚生省的一个小组周三表示，不一致的试验结果使得很难确定卫材公司和百健公司开发的阿尔茨海默氏症治疗方法的疗效。</blockquote></p><p> Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p><p><blockquote>总部位于东京的卫材及其美国合作伙伴一年多前向日本监管机构申请了药物Aduhelm的批准，该药物于6月在美国获得批准。</blockquote></p><p> In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p><p><blockquote>在一份声明中，该小组引用了全球III期试验的不一致结果，以及该药物减少大脑斑块的能力缺乏临床意义。该小组表示，如果提交进一步的数据，它将重新审视。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen shares fell 1.2% in early trading<blockquote>百健(Biogen)股价早盘下跌1.2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen shares fell 1.2% in early trading<blockquote>百健(Biogen)股价早盘下跌1.2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-22 22:51</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Biogen&nbsp;shares&nbsp;fell&nbsp;1.2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p><p><blockquote>百健(Biogen)股价早盘下跌1.日本厚生省的一个小组周三表示，不一致的试验结果使得很难确定卫材公司和百健公司开发的阿尔茨海默氏症治疗方法的疗效。</blockquote></p><p> Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p><p><blockquote>总部位于东京的卫材及其美国合作伙伴一年多前向日本监管机构申请了药物Aduhelm的批准，该药物于6月在美国获得批准。</blockquote></p><p> In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p><p><blockquote>在一份声明中，该小组引用了全球III期试验的不一致结果，以及该药物减少大脑斑块的能力缺乏临床意义。该小组表示，如果提交进一步的数据，它将重新审视。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104039472","content_text":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.\nTokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.\nIn a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":2115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691207005,"gmtCreate":1640190124033,"gmtModify":1640190124325,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"Is this the chance for 1.5k price target?","listText":"Is this the chance for 1.5k price target?","text":"Is this the chance for 1.5k price target?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691207005","repostId":"2193192720","repostType":4,"isVote":1,"tweetType":1,"viewCount":1846,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691204291,"gmtCreate":1640190086815,"gmtModify":1640190086924,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>should I sell it now?","listText":"<a href=\"https://laohu8.com/S/MSFT\">$Microsoft(MSFT)$</a>should I sell it now?","text":"$Microsoft(MSFT)$should I sell it now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/691204291","isVote":1,"tweetType":1,"viewCount":2698,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691648128,"gmtCreate":1640188002072,"gmtModify":1640188002186,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>$1500 in 2022?","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>$1500 in 2022?","text":"$Tesla Motors(TSLA)$$1500 in 2022?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691648128","isVote":1,"tweetType":1,"viewCount":2320,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691907269,"gmtCreate":1640107492499,"gmtModify":1640107492574,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>Fell again? :(","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>Fell again? :(","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$Fell again? :(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691907269","isVote":1,"tweetType":1,"viewCount":2191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699801629,"gmtCreate":1639763467860,"gmtModify":1639763467941,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699801629","repostId":"2192597562","repostType":4,"isVote":1,"tweetType":1,"viewCount":3411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690247639,"gmtCreate":1639673367609,"gmtModify":1639673367685,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>up to 1.80?","listText":"<a href=\"https://laohu8.com/S/AVCT\">$American Virtual Cloud Technologies, Inc.(AVCT)$</a>up to 1.80?","text":"$American Virtual Cloud Technologies, Inc.(AVCT)$up to 1.80?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690247639","isVote":1,"tweetType":1,"viewCount":2603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607704818,"gmtCreate":1639583762197,"gmtModify":1639583785108,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>Close at 3.30 tonight? Possible?&nbsp;","listText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>Close at 3.30 tonight? Possible?&nbsp;","text":"$Galera Therapeutics, Inc.(GRTX)$Close at 3.30 tonight? Possible?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607704818","isVote":1,"tweetType":1,"viewCount":2083,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607129064,"gmtCreate":1639500685977,"gmtModify":1639500686076,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>up to 3.05?&nbsp;","listText":"<a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a>up to 3.05?&nbsp;","text":"$Galera Therapeutics, Inc.(GRTX)$up to 3.05?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607129064","isVote":1,"tweetType":1,"viewCount":2740,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604582766,"gmtCreate":1639412042863,"gmtModify":1639412764935,"author":{"id":"4098271159372920","authorId":"4098271159372920","name":"zetheraine","avatar":"https://static.tigerbbs.com/8837a06e7c83687d978d4c2954d0e13a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098271159372920","idStr":"4098271159372920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NES\">$Nuverra Environmental Solutions, Inc.(NES)$</a>omgness it dropped after I buy 😔","listText":"<a href=\"https://laohu8.com/S/NES\">$Nuverra Environmental Solutions, Inc.(NES)$</a>omgness it dropped after I buy 😔","text":"$Nuverra Environmental Solutions, Inc.(NES)$omgness it dropped after I buy 😔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604582766","isVote":1,"tweetType":1,"viewCount":2045,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}